Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 9 matching records.
9 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network
Narrative Review, published in Genes Dis (2024) — summary generated from the PubMed abstract.
- 2024
Genes Dis20 citations - Level DAnimal StudyPubMed
Fibroblast Growth Factor 21 Exerts its Anti-inflammatory Effects on Multiple Cell Types of Adipose Tissue in Obesity.
Animal Study on Type 2 Diabetes, Chronic Inflammation, published in Obesity (Silver Spring) (2019) — summary generated from the PubMed abstract.
- 2019
Obesity (Silver Spring)32 citations - Level DAnimal StudyEurope PMC
Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat
Animal Study on Type 2 Diabetes, published in Nat Commun (2018) — summary generated from the PubMed abstract.
- 2018
Nat Commun133 citations - Level DNarrative ReviewEurope PMC
Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis
Narrative Review on Systemic / IV, published in Annu Rev Nutr (2018) — summary generated from the PubMed abstract.
- 2018
Annu Rev Nutr174 citations - Level DAnimal StudyPubMed
BMP-9 enhances fibroblast growth factor 21 expression and suppresses obesity.
Animal Study, published in Biochim Biophys Acta (2016) — summary generated from the PubMed abstract.
- 2016
Biochim Biophys Acta - Level DAnimal StudyEurope PMC
Central Fibroblast Growth Factor 21 Browns White Fat via Sympathetic Action in Male Mice
Animal Study, published in Endocrinology (2015) — summary generated from the PubMed abstract.
- 2015
Endocrinology169 citations - Level DLaboratory StudyPubMed
Fibroblast growth factor 21 improves insulin sensitivity and synergizes with insulin in human adipose stem cell-derived (hASC) adipocytes.
Laboratory Study on Type 2 Diabetes, published in PLoS One (2014) — summary generated from the PubMed abstract.
- 2014
PLoS One29 citations - Level DAnimal StudyEurope PMC
Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones
Animal Study, published in Cell (2012) — summary generated from the PubMed abstract.
- 2012
Cell449 citations - Level DAnimal StudyEurope PMC
βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism
Animal Study on Type 2 Diabetes, published in Cell Metab (2012) — summary generated from the PubMed abstract.
- 2012
Cell Metab341 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406